Literature DB >> 2745682

Laboratory investigation of hospital outbreak caused by two different multiresistant Acinetobacter calcoaceticus subsp. anitratus strains.

J Vila1, M Almela, M T Jimenez de Anta.   

Abstract

During a 7-month period, from December 1986 to June 1987, multiresistant strains of Acinetobacter calcoaceticus subsp. anitratus were isolated from 25 patients in a respiratory intensive care unit. The biochemical characteristics defined two groups of strains, group 1 (14 strains) and group 2 (11 strains). Both groups had the same biochemical characteristics, but group 2 strains could assimilate adipate and phenyl acetate. Moreover, of 16 antibiotics tested only netilmicin and imipenem had some inhibitory activity for group 1 strains; group 2 strains were susceptible to mezlocillin, piperacillin, and ticarcillin. Plasmid profiles of the groups were also different. The results of a laboratory investigation (biochemical characteristics, antibiotic susceptibility, and plasmid isolation) identified two different A. calcoaceticus subsp. anitratus strains as the causes of the outbreak.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2745682      PMCID: PMC267488          DOI: 10.1128/jcm.27.5.1086-1089.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  [The formation of the skeleton. I. Growth of a long bone. 1st appearance of a center of calcification].

Authors:  M Juster; A Moscofian
Journal:  Pathol Biol (Paris)       Date:  1971-01

2.  Isolation of Acinetobacter from soil and water.

Authors:  P Baumann
Journal:  J Bacteriol       Date:  1968-07       Impact factor: 3.490

3.  A study of the Moraxella group. II. Oxidative-negative species (genus Acinetobacter).

Authors:  P Baumann; M Doudoroff; R Y Stanier
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

4.  Activity of minocycline against Acinetobacter calcoaceticus var. anitratus (syn. Herellea vaginicola) and Serratia marcescens.

Authors:  E G Maderazo; R Quintiliani; R C Tilton; R Bartlett; N C Joyce; V T Andriole
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

5.  Community-acquired Acinetobacter pneumonia.

Authors:  M L Fernández Guerrero; J L Díaz Fernández; J de Miguel Prieto; J L Gómez Garcés
Journal:  Chest       Date:  1980-10       Impact factor: 9.410

6.  Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.

Authors:  S D Lang; D J Edwards; D T Durack
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

7.  Nosocomial respiratory tract infection and colonization with Acinetobacter calcoaceticus. Epidemiologic characteristics.

Authors:  A E Buxton; R L Anderson; D Werdegar; E Atlas
Journal:  Am J Med       Date:  1978-09       Impact factor: 4.965

8.  Acinetobacter calcoaceticus variety anitratus: an increasing nosocomial problem.

Authors:  R Ramphal; R M Kluge
Journal:  Am J Med Sci       Date:  1979 Jan-Feb       Impact factor: 2.378

9.  Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies.

Authors:  R H Glew; R C Moellering; L J Kunz
Journal:  Medicine (Baltimore)       Date:  1977-03       Impact factor: 1.889

10.  A common source outbreak of Acinetobacter pulmonary infections traced to Wright respirometers.

Authors:  B A Cunha; J J Klimek; J Gracewski; J C McLaughlin; R Quintiliani
Journal:  Postgrad Med J       Date:  1980-03       Impact factor: 2.401

View more
  16 in total

Review 1.  Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.

Authors:  E Bergogne-Bérézin; K J Towner
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

2.  Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations.

Authors:  M B Marques; E S Brookings; S A Moser; P B Sonke; K B Waites
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

3.  Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods.

Authors:  J Tankovic; P Legrand; G De Gatines; V Chemineau; C Brun-Buisson; J Duval
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

4.  Endemic acinetobacter in intensive care units: epidemiology and clinical impact.

Authors:  L Dijkshoorn; R van Dalen; A van Ooyen; D Bijl; I Tjernberg; M F Michel; A M Horrevorts
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

5.  In vitro susceptibility of Acinetobacter baumannii to biapenem, piperacillin/tazobactam and thirteen other antimicrobial agents.

Authors:  A E Simor; L Louie; M Louie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-06       Impact factor: 3.267

6.  Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to an epidemic strain.

Authors:  J Vila; J Ruiz; M Navia; B Becerril; I Garcia; S Perea; I Lopez-Hernandez; I Alamo; F Ballester; A M Planes; J Martinez-Beltran; T J de Anta
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Use of pulsed-field gel electrophoresis for investigation of hospital outbreaks of Acinetobacter baumannii.

Authors:  A Gouby; M J Carles-Nurit; N Bouziges; G Bourg; R Mesnard; P J Bouvet
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

8.  Infective endocarditis of an interventricular patch caused by Acinetobacter haemolyticus.

Authors:  E Castellanos Martínez; M Telenti Asensio; V M Rodríguez Blanco; M L Rodríguez Suárez; A Morena Torrico; A Cortina Llosa
Journal:  Infection       Date:  1995 Jul-Aug       Impact factor: 3.553

9.  In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii.

Authors:  J Vila; A Marcos; F Marco; S Abdalla; Y Vergara; R Reig; R Gomez-Lus; T Jimenez de Anta
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

10.  Discrimination of epidemic and sporadic isolates of Acinetobacter baumannii by repetitive element PCR-mediated DNA fingerprinting.

Authors:  A C Reboli; E D Houston; J S Monteforte; C A Wood; R J Hamill
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.